Using RWE to Make Cost Decisions: A New Report
A recent article, published in JMCP (the Journal of Managed Care and Specialty Pharmacy), considers how RWE (real world… Read more
HEOR Feature
Featured
RWE Expert Discusses Ripple Effects of FDA Framework Throughout Pharma
In a recent interview, Roche’s Global Head of Real World Evidence (RWE) and Market Access Sreeram Ramagopalan shared his thoughts on the evolving role… Read more
Evidence Partners Highlights the Time-Saving Power of AI in COVID-19 Data Extraction Case Study
In a recently described case study, a health agency was able to cut costs by using the DistillerSR artificial intelligence (AI) data extraction tool.… Read more
Kaiser Family Foundation Executive Discusses Medicare Drug Pricing Legislation
Executive Vice President for Health Policy at the Kaiser Family Foundation Larry Levitt shared his thoughts on the Congressional Budget Office’s… Read more
The Latest Blogs from tHEORetically Speaking
- Education Spotlight: European Market Access University Diploma (EMAUD)
- Supplier Spotlight: PicnicHealth
- Is Cost-Effectiveness Analysis Racist?
- Generating evidence for optimal market access – an Executive Interview with Jeff Anderson and Rosemary Jose, OPEN Health
- All About the Value, Evidence and Access Marketplace: Interview with Scientist.com Category Experts
